搜索
技术平台

Whole genome sequencing

Product Description
Case Interpretation

Whole Genome Sequencing (WGS) is a genome-wide sequencing method that can decipher all common and rare variants, single nucleotide polymorphisms (SNP), insertion and deletion sites (InDel), structural variants (SV) and copy number variants (CNV), and thus reveal all types of genomic mutations and chromosomal rearrangement events. This will provide guidance for disease mechanism research and drug target screening. Applications include clinical medicine, population genetics, association analysis, evolutionary analysis and so on.

 

technology roadmap

1

 

technical parameter

 

Technical Parameters

Sequencing strategy

Lead time

Sample type: Genomic DNA

Sample concentration: ≥20 ng/μl (Qubit quantification)

Total sample mass: ≥3.0 μg (total of 3 library builds, excluding consuming of sample assay, Qubit quantification)

Sample purity:  OD260/280 =1.7~2.2

Electrophoresis requirements: clear primary bands, no degradation or light degradation, no serious RNA or protein contamination (latest electrophoresis results of the sample delivery date).

 

Sequencing mode: Illumina/MGI

Sequencing depth: 30X recommended

45 days

 

Product advantages

a. High accuracy: Using the Illumina /MGI platform by which more than a million sequences can be performed in a single run, with accurate counts ranging from several to hundreds of thousands copies;

b. Wide detection range: single nucleotide polymorphism (SNP), insertion deletion (InDel), structural variation (SV), copy number variation (CNV) and other variants can be detected, and new variant sequences can be detected compared to microarrays;

c. Low cost and less time consuming than whole human genome de novo sequencing.

Case Interpretations.

Case 1 Genomic variation mapping reveals the origin of cultivated rice

Background

Cultivated rice is one of the most important crops and has been domesticated from wild rice for thousands of years. Cultivated rice is one of the most important developments in human history and has greatly contributed to the development of human civilization, but its origin and domestication process was controversial.

Study

In this study, the researchers used rice as the material, and carried out whole-genome sequencing of 446 wild rice species and 1083 cultivated japonica and indica rice species from different regions. The researchers constructed a relatively comprehensive map of the structural variation of the rice genome, revealing the domestication and origin process of cultivated japonica and indica rice, and provided important genetic resources for molecular breeding of rice, as well as  important genomic approach for crop domestication research.

 

 

1

 

Figure 1. Domestication and origin of cultivated rice

 

Results

1. Based on whole genome sequencing, NJ tree and PCA analysis, 446 wild rice from different regions could be classified into three types: Or-I, Or-II and Or-III, and there was a strong correlation between the classification and geographical distribution;

2. resequencing analysis of 1083 cultivated japonica rice and indica rice revealed that cultivated japonica rice and indica rice originated from Or-I and Or-III, respectively;

3. the domestication of japonica rice originated earlier than indica rice.

Case 2 Ultra-low depth whole genome sequencing based on cfDNA to differentiate benign and malignant neurofibroma lesions

Background

Neurofibromatosis type 1 (NF1) is a common hereditary syndrome of cancer susceptibility. Malignant peripheral nerve sheath tumour (MPNST), an aggressive soft tissue sarcoma caused by a benign plexiform neurofibroma (PN) precursor lesion, is the leading cause of death in patients with NF1. Accurate diagnosis of the transition from PN to MPNST is challenging, as cross-sectional imaging findings of the two are difficult to differentiate, and intra-lesional heterogeneity may lead to false-negative biopsy results, often causing delayed diagnosis of MPNST and even worsening prognosis.

Study

The team prospectively collected blood samples from 23 patients with PN, 14 patients with MPNST who had not yet received treatment and 16 healthy individuals. The cfDNA was isolated from the blood samples and analysed using ULP-WGS for cfDNA detection. The aim was to differentiate MPNST from benign PN in a non-invasive manner by analysing and quantifying genomic copy number variants (CNA) in plasma cfDNA.

 

 

1

Figure 1. Overview of the study

 

Results

ULP-WGS is a highly sensitive and quick and simple method to non-invasively differentiate patients with MPNST from benign precursors, providing the first evidence of the ability of liquid biopsy to differentiate benign from malignant tumours in hereditary cancer susceptibility syndromes. This liquid biopsy technique can determine ambiguous imaging findings and has the potential to monitor PN patients as a biomarker test for MRD and treatment response, facilitating early detection of MPNST and laying the foundation for improved early cancer detection and surveillance in high-risk cancer susceptible populations.

reference

  1. Huang X, Kurata N, Wei X, et al. A map of rice genome variation reveals the origin of cultivated rice[J]. Nature, 2012, 490(7421):497-501.

  2. Li, S., Noor, Z.S., Zeng, W. et al. Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis. Nat Commun 12, 4172(2021)

  3. Peneder, P., Stütz, A.M., Surdez, D. et al. Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden. Nat Commun 12, 3230(2021)

Follow us

Link: